INSERM, EFS, University of Montpellier, Montpellier, France; Department of Biology and Pathology, University of Montpellier Hospital, Montpellier, France.
INSERM, EFS, University of Montpellier, Montpellier, France.
J Clin Virol. 2018 Feb-Mar;99-100:79-83. doi: 10.1016/j.jcv.2018.01.006. Epub 2018 Jan 16.
African women living with HIV (WLHIV) are at high risk of cervical cancer but rarely adequately screened. Better strategies enabling identification of WLHIV with high-grade cervical intraepithelial lesions (CIN2+) are required.
To investigate the diagnostic value of HPV16 and HPV18 viral loads in a cohort of African WLHIV.
HPV16 and HPV18 viral loads were determined by quantitation of the E6 gene DNA by real-time PCR in cervical specimens collected at baseline and endline (16 months) from 245 African WLHIV positive for HPV16 or/and HPV18. Cervical biopsies were graded using the histopathological CIN classification.
Women with CIN2+ had higher viral load for HPV16 (p < 0.0001) or HPV18 (p = 0.03) than those without CIN2+. HPV16 viral load ≥3.59 log copies/1000 cells detected CIN2+ with sensitivity and specificity of 93.5% (95%CI: 81.7-98.3%) and 74.1% (95%CI: 66.3-80.6%), respectively, whereas HPV18 viral load ≥1.63 log copies/1000 cells detected CIN2+ with sensitivity and specificity of 59.1% (95%CI: 38.7-76.7%) and 66.9% (95%CI: 58.8-74.1%), respectively. A high baseline HPV16 viral load was significantly associated with persistence of, or progression to CIN2+ at endline; these findings were not observed for HPV18.
HPV16 viral load is a powerful marker of CIN2+ in African WLHIV. HPV18 viral load is of lower diagnostic value in this population.
感染艾滋病毒的非洲女性(WLHIV)患宫颈癌的风险很高,但很少得到充分筛查。需要更好的策略来识别患有高级别宫颈上皮内瘤变(CIN2+)的 WLHIV。
研究 HPV16 和 HPV18 病毒载量在非洲 WLHIV 队列中的诊断价值。
通过实时 PCR 定量宫颈标本中 E6 基因 DNA,检测 245 例 HPV16 或/和 HPV18 阳性的非洲 WLHIV 基线和终点(16 个月)时的 HPV16 和 HPV18 病毒载量。宫颈活检采用组织病理学 CIN 分级。
患有 CIN2+的女性 HPV16(p<0.0001)或 HPV18(p=0.03)病毒载量高于无 CIN2+的女性。HPV16 病毒载量≥3.59log 拷贝/1000 细胞检测 CIN2+的敏感性和特异性分别为 93.5%(95%CI:81.7-98.3%)和 74.1%(95%CI:66.3-80.6%),而 HPV18 病毒载量≥1.63log 拷贝/1000 细胞检测 CIN2+的敏感性和特异性分别为 59.1%(95%CI:38.7-76.7%)和 66.9%(95%CI:58.8-74.1%)。基线时高 HPV16 病毒载量与终点时 CIN2+的持续存在或进展显著相关;这些发现与 HPV18 无关。
HPV16 病毒载量是非洲 WLHIV 中 CIN2+的有力标志物。HPV18 病毒载量在该人群中的诊断价值较低。